Minnesota Oncology is pleased to announce that Jesus Vera Aguilera, MD has recently joined our Fridley and Maple Grove clinics.
“Cancer treatment is challenging for patients and families; my purpose is to be a friendly hand to go along the journey of cancer diagnosis and treatment. My commitment is to provide our patients with competent, empathetic, and compassionate care. I strive to find new therapies, clinical trials, and multidisciplinary approaches to help our patients during adversity.”
Dr. Vera received his medical degree from the National Autonomous University of Mexico. He completed his residency in internal medicine at Texas Tech University Health Sciences Center, Odessa, TX. His Hematology and Medical Oncology Fellowship was completed at the Mayo School of Health Sciences, Rochester, MN.
Dr Vera’s areas of special interest include:
- Melanoma
- Lung Cancer
- Gastrointestinal Malignancies
- Immunotherapy
- Clinical trials/Novel therapies
His medical affiliations include:
- NCI Community Oncology Research Program (NCORP) Member
- Mayo Fellows’ Association – Rochester
- American Society of Clinical Oncology
- American Society of Hematology
Dr. Vera loves to spend time with his family and long walks with his dog. He enjoys traveling and experiencing new cultures and food.
Appointments with Dr. Vera can be made by calling 844.317.4673 or by requesting an appointment online.
Share
Categories
Tags
Recent Posts
Reflecting on her experience with Minnesota Oncology, Diane is filled with gratitude. “If you find yourself in the involuntary ‘cancer club,’ there is no better place to be than Minnesota Oncology.
This is the story about the origin of the Angel Foundation. Minnesota Oncology has long supported the Angel Foundation through sponsorships, employee-driven fundraisers, volunteerism, and payroll deduction. But many may not know why our two organizations are so close and how the foundation started.
Exposure to bacteria may contribute to rising rates of colorectal cancer in young adults. Colorectal cancer has moved from being the fourth leading of cause of cancer related death in both men and women under the age of 50 two decades ago to being number one in men and second in women.